These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18813135)

  • 21. Commentary on population screening for fragile X syndrome.
    Coffee B
    Genet Med; 2010 Jul; 12(7):411-2. PubMed ID: 20535018
    [No Abstract]   [Full Text] [Related]  

  • 22. Fragile X syndrome.
    Welch JL; Williams JK
    Neonatal Netw; 1999 Sep; 18(6):15-22. PubMed ID: 10690095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing for fragile X gene mutations throughout the life span.
    Hagerman RJ; Hagerman PJ
    JAMA; 2008 Nov; 300(20):2419-21. PubMed ID: 19033593
    [No Abstract]   [Full Text] [Related]  

  • 24. A majority of parents accept newborn screening for fragile X.
    Levenson D
    Am J Med Genet A; 2011 Sep; 155A(9):viii-ix. PubMed ID: 21853527
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessing the Fragile X Syndrome Newborn Screening Landscape.
    Riley C; Wheeler A
    Pediatrics; 2017 Jun; 139(Suppl 3):S207-S215. PubMed ID: 28814541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fragile X syndrome: implications of molecular genetics for the clinical syndrome.
    Rousseau F
    Eur J Clin Invest; 1994 Jan; 24(1):1-10. PubMed ID: 8187801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexistence of Fragile-X Syndrome, 8p23.1 Deletion, and Balanced Translocation t(7;10)(p10;q24) in a Single Family.
    Cortés H; Reyes-Rosales M; Rojas-Velasco AJ; García-Juárez B; Tapia-Guerrero YS; Arenas-Diaz S; Leyva-García N; Macías-Gallardo JJ; Carrillo-Mora P; Magaña JJ
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):527-531. PubMed ID: 32716213
    [No Abstract]   [Full Text] [Related]  

  • 28. Parents' decisions to screen newborns for FMR1 gene expansions in a pilot research project.
    Skinner D; Choudhury S; Sideris J; Guarda S; Buansi A; Roche M; Powell C; Bailey DB
    Pediatrics; 2011 Jun; 127(6):e1455-63. PubMed ID: 21624881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular diagnosis of fragile X syndrome].
    Ben Jemaa L; Khemir S; Maazoul F; Richard L; Beldjord C; Chaabouni M; Chaabouni H
    Tunis Med; 2008 Nov; 86(11):973-7. PubMed ID: 19213487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women.
    Archibald AD; Jaques AM; Wake S; Collins VR; Cohen J; Metcalfe SA
    Am J Med Genet A; 2009 Dec; 149A(12):2731-8. PubMed ID: 19938084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-risk fragile x screening in Guatemala: use of a new blood spot polymerase chain reaction technique.
    Yuhas J; Walichiewicz P; Pan R; Zhang W; Casillas EM; Hagerman RJ; Tassone F
    Genet Test Mol Biomarkers; 2009 Dec; 13(6):855-9. PubMed ID: 19810826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethical and policy issues in newborn screening of children for neurologic and developmental disorders.
    Ross LF
    Pediatr Clin North Am; 2015 Jun; 62(3):787-98. PubMed ID: 26022175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragile X mental retardation syndrome: DNA diagnosis and carrier detection in New Zealand families.
    Neville L; Cochrane J; Fitzgerald P; Kennedy M
    N Z Med J; 1995 Oct; 108(1009):404-6. PubMed ID: 7478333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatricians' attitudes toward expanding newborn screening.
    Acharya K; Ackerman PD; Ross LF
    Pediatrics; 2005 Oct; 116(4):e476-84. PubMed ID: 16199673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health supervision for children with fragile X syndrome.
    Hersh JH; Saul RA;
    Pediatrics; 2011 May; 127(5):994-1006. PubMed ID: 21518720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation analysis of fragile X-related epigenetic elements may provide a suitable newborn screening test for fragile X syndrome.
    Godler DE; Slater HR; Amor D; Loesch DZ
    Genet Med; 2010 Sep; 12(9):595. PubMed ID: 20838083
    [No Abstract]   [Full Text] [Related]  

  • 37. ACOG Committee Opinion No. 469: Carrier screening for fragile X syndrome.
    Obstet Gynecol; 2010 Oct; 116(4):1008-1010. PubMed ID: 20859177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three peaks in the polymerase chain reaction fragile X analysis.
    Sharony R; Shtorch A; Amiel A; Guetta E; Peleg L; Pras E; Ries-Levavi L
    J Med Screen; 2012 Sep; 19(3):112-5. PubMed ID: 23093728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fragile X Syndrome: A Review for General Pediatricians.
    Mendez A; Mendez M
    Pediatr Ann; 2024 Jul; 53(7):e269-e271. PubMed ID: 38949875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.
    Bailey DB; Skinner D; Davis AM; Whitmarsh I; Powell C
    Pediatrics; 2008 Mar; 121(3):e693-704. PubMed ID: 18310190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.